Related Experiment Video
Updated: May 28, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
[An era of international collaboration in pediatric rheumatology]
1Pediatric Rheumatology, Department of Pediatrics, Meir Medical Center, Kfar Saba, Sackler Faculty of Medicine, Tel Aviv University, Israel. uziely@zahav.net.il
Insights
International collaboration in pediatric rheumatology research has grown significantly, enabling crucial studies on rare diseases. This has led to important findings in epidemiology, genetics, and treatment for pediatric rheumatic conditions.
Area of Science:
- Pediatric Rheumatology
- Rare Diseases
- Multicenter Research
Context:
- Pediatric rheumatologic diseases are rare, necessitating collaborative research efforts.
- Meaningful research requires large patient cohorts, achievable through multicenter studies.
- Global collaboration has expanded significantly in pediatric rheumatology over the past two decades.
Purpose:
- To describe the evolution of international collaboration in pediatric rheumatology.
- To highlight key research findings from major international studies.
- To underscore the importance of multicenter research for rare pediatric diseases.
Summary:
- International collaboration has transformed pediatric rheumatology research, moving from isolated efforts to a global network of hundreds of centers.
- This collaborative approach facilitates the enrollment of adequate patient numbers for comprehensive studies on disease epidemiology, diagnostic criteria, genetics, pathogenesis, outcomes, and treatment.
- Significant research advancements have been achieved through major international studies focusing on prevalent pediatric rheumatic conditions.
Impact:
- Enabled large-scale epidemiological studies for rare pediatric rheumatic diseases.
- Facilitated the development of standardized diagnostic and classification criteria.
- Advanced understanding of genetic predispositions, disease pathogenesis, and treatment protocols.
- Improved patient outcomes through evidence-based treatment strategies derived from international research.
Abstract:
Since pediatric rheumatology diseases are rare, multicenter and even international collaboration is necessary to perform meaningful research. Multicenter research can enable rapid enrollment of sufficient numbers of patients for studies of epidemiology, diagnostic and classification criteria, genetic disease predisposition, pathogenesis, outcome and treatment protocols. In the last 20 years the vision of few has become a reality of collaboration of several hundred centers around the world in pediatric rheumatology research. In this paper we will describe the evolution of this international collaboration and important research findings that resulted from key international studies on the major pediatric rheumatology diseases.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease III: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Distribution
Rheumatic Heart Disease IV: Nursing Management